Willem van den Hout

Research Associate, Biochemistry at Ambagon Therapeutics

No bio yet


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Ambagon Therapeutics

Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.